{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:52:36Z","timestamp":1790895156757,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,1,20]],"date-time":"2004-01-20T00:00:00Z","timestamp":1074556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,1,26]]},"DOI":"10.1038\/sj.bjc.6601503","type":"journal-article","created":{"date-parts":[[2004,1,20]],"date-time":"2004-01-20T18:41:36Z","timestamp":1074624096000},"page":"503-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma"],"prefix":"10.1038","volume":"90","author":[{"given":"N","family":"Soufir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"Lacapere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Matichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Meziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Mirebeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Archimbaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Ollivaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Bouscarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Baccard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sa\u00efag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Lebb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Basset-Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Crickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Cave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Grandchamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,1,20]]},"reference":[{"key":"BF6601503_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/jnci\/91.5.446","volume":"91","author":"J Aitken","year":"1999","unstructured":"Aitken J, Welch J, Duffy D, Milligan A, Green A, Martin N, Hayward N (1999) CDKN2A variants in a population-based sample of Queensland families with melanoma. J Natl Cancer Inst 91: 446\u2013452","journal-title":"J Natl Cancer Inst"},{"key":"BF6601503_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00008390-200212000-00005","volume":"12","author":"JP Alao","year":"2002","unstructured":"Alao JP, Mohammed MQ, Retsas S (2002) The CDKN2A tumour suppressor gene: no mutations detected in patients with melanoma and additional unrelated cancers. Melanoma Res 12: 559\u2013563","journal-title":"Melanoma Res"},{"key":"BF6601503_CR3","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.1038\/sj.onc.1203012","volume":"18","author":"M Ashcroft","year":"1999","unstructured":"Ashcroft M, Vousden KH (1999) Regulation of p53 stability. Oncogene 18: 7637\u20137643","journal-title":"Oncogene"},{"key":"BF6601503_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/gcc.1183","volume":"32","author":"S Auroy","year":"2001","unstructured":"Auroy S, Avril MF, Chompret A, Pham D, Goldstein AM, Bianchi-Scarra G, Frebourg T, Joly P, Spatz A, Rubino C, Demenais F, Bressac-de Paillerets B (2001) Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect. Genes Chromosomes Cancer 32: 195\u2013202","journal-title":"Genes Chromosomes Cancer"},{"key":"BF6601503_CR5","first-page":"2298","volume":"58","author":"M Bahuau","year":"1998","unstructured":"Bahuau M, Vidaud D, Jenkins RB, Bieche I, Kimmel DW, Assouline B, Smith JS, Alderete B, Cayuela JM, Harpey JP, Caille B, Vidaud M (1998) Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res 58: 2298\u20132303","journal-title":"Cancer Res"},{"key":"BF6601503_CR6","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1093\/hmg\/10.16.1701","volume":"10","author":"M Bastiaens","year":"2001","unstructured":"Bastiaens M, ter Huurne J, Gruis N, Bergman W, Westendorp R, Vermeer BJ, Bavinck JN (2001) The melanocortin-1-receptor gene is the major freckle gene. Hum Mol Genet 10: 1701\u20131708","journal-title":"Hum Mol Genet"},{"key":"BF6601503_CR7","first-page":"3282","volume":"7","author":"TM Becker","year":"2001","unstructured":"Becker TM, Rizos H, Kefford RF, Mann GJ (2001) Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent Kinase 4 binding. Clin Cancer Res 7: 3282\u20133288","journal-title":"Clin Cancer Res"},{"key":"BF6601503_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/gcc.10188","volume":"37","author":"R Bertin","year":"2003","unstructured":"Bertin R, Acquaviva C, Mirebeau D, Guidal-Giroux C, Vilmer E, Cave H (2003) CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 37: 44\u201357","journal-title":"Genes Chromosomes Cancer"},{"key":"BF6601503_CR9","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1046\/j.1523-1747.2002.01825.x","volume":"119","author":"CG Bertram","year":"2002","unstructured":"Bertram CG, Gaut RM, Barrett JH, Pinney E, Whitaker L, Turner F, Bataille V, Dos Santos Silva I, A JS, Bishop DT, Newton Bishop JA (2002) An assessment of the CDKN2A variant Ala148Thr as a nevus\/melanoma susceptibility allele. J Invest Dermatol 119: 961\u2013965","journal-title":"J Invest Dermatol"},{"key":"BF6601503_CR10","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/jnci\/92.15.1260","volume":"92","author":"A Borg","year":"2000","unstructured":"Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Masback A, Westerdahl J, Olsson H, Ingvar C (2000) High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 92: 1260\u20131266","journal-title":"J Natl Cancer Inst"},{"key":"BF6601503_CR11","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1182\/blood.V95.5.1869.005k09_1869_1871","volume":"95","author":"D Dilworth","year":"2000","unstructured":"Dilworth D, Liu L, Stewart AK, Berenson JR, Lassam N, Hogg D (2000) Germline CDKN2A mutation implicated in predisposition to multiple myeloma. Blood 95: 1869\u20131871","journal-title":"Blood"},{"key":"BF6601503_CR12","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1038\/sj.onc.1201470","volume":"15","author":"JF Flores","year":"1997","unstructured":"Flores JF, Pollock PM, Walker GJ, Glendening JM, Lin AH, Palmer JM, Walters MK, Hayward NK, Fountain JW (1997) Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds. Oncogene 15: 2999\u20133005","journal-title":"Oncogene"},{"key":"BF6601503_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0301-472X(02)00806-8","volume":"30","author":"DG Ginzinger","year":"2002","unstructured":"Ginzinger DG (2002) Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 30: 503\u2013512","journal-title":"Exp Hematol"},{"key":"BF6601503_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00008390-200202000-00008","volume":"12","author":"AM Goldstein","year":"2002","unstructured":"Goldstein AM, Chidambaram A, Halpern A, Holly EA, Guerry ID, Sagebiel R, Elder DE, Tucker MA (2002) Rarity of CDK4 germline mutations in familial melanoma. Melanoma Res 12: 51\u201355","journal-title":"Melanoma Res"},{"key":"BF6601503_CR15","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJM199510123331504","volume":"333","author":"AM Goldstein","year":"1995","unstructured":"Goldstein AM, Fraser MC, Struewing JP, Hussussian CJ, Ranade K, Zametkin DP, Fontaine LS, Organic SM, Dracopoli NC, Clark Jr WH, Tucker MA (1995) Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations [see comments]. N Engl J Med 333: 970\u2013974","journal-title":"N Engl J Med"},{"key":"BF6601503_CR16","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11+<2464::AID-CNCR3>3.0.CO;2-F","volume":"86","author":"MH Greene","year":"1999","unstructured":"Greene MH (1999) The genetics of hereditary melanoma and nevi. 1998 update. Cancer 86: 2464\u20132477","journal-title":"Cancer"},{"key":"BF6601503_CR17","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/(SICI)1097-0215(19970904)72:5<780::AID-IJC13>3.0.CO;2-D","volume":"72","author":"P Guldberg","year":"1997","unstructured":"Guldberg P, Kirkin AF, Gronbaek K, thor Straten P, Ahrenkiel V, Zeuthen J (1997) Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: a novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma. Int J Cancer 72: 780\u2013783","journal-title":"Int J Cancer"},{"key":"BF6601503_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/(SICI)1098-2264(200005)28:1<45::AID-GCC6>3.0.CO;2-F","volume":"28","author":"M Harland","year":"2000","unstructured":"Harland M, Holland EA, Ghiorzo P, Mantelli M, Bianchi-Scarra G, Goldstein AM, Tucker MA, Ponder BA, Mann GJ, Bishop DT, Newton Bishop J (2000) Mutation screening of the CDKN2A promoter in melanoma families. Genes Chromosomes Cancer 28: 45\u201357","journal-title":"Genes Chromosomes Cancer"},{"key":"BF6601503_CR19","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/hmg\/6.12.2061","volume":"6","author":"M Harland","year":"1997","unstructured":"Harland M, Meloni R, Gruis N, Pinney E, Brookes S, Spurr NK, Frischauf AM, Bataille V, Peters G, Cuzick J, Selby P, Bishop DT, Bishop JN (1997) Germline mutations of the CDKN2 gene in UK melanoma families. Hum Mol Genet 6: 2061\u20132067","journal-title":"Hum Mol Genet"},{"key":"BF6601503_CR20","first-page":"6864","volume":"60","author":"J Hashemi","year":"2000","unstructured":"Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J (2000) CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas. Cancer Res 60: 6864\u20136867","journal-title":"Cancer Res"},{"key":"BF6601503_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11912-000-0022-z","volume":"2","author":"N Hayward","year":"2000","unstructured":"Hayward N (2000) New developments in melanoma genetics. Curr Oncol Rep 2: 300\u2013306","journal-title":"Curr Oncol Rep"},{"key":"BF6601503_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<339::AID-GCC5>3.0.CO;2-H","volume":"25","author":"EA Holland","year":"1999","unstructured":"Holland EA, Schmid H, Kefford RF, Mann GJ (1999) CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas. Genes Chromosomes Cancer 25: 339\u2013348","journal-title":"Genes Chromosomes Cancer"},{"key":"BF6601503_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ng0994-15","volume":"8","author":"CJ Hussussian","year":"1994","unstructured":"Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark Jr WH, Tucker MA, Dracopoli NC (1994) Germline p16 mutations in familial melanoma. Nat Genet 8: 15\u201321","journal-title":"Nat Genet"},{"key":"BF6601503_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ng0994-22","volume":"8","author":"A Kamb","year":"1994","unstructured":"Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J et al. (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8: 23\u201326","journal-title":"Nat Genet"},{"key":"BF6601503_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","volume":"91","author":"T Kamijo","year":"1997","unstructured":"Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ (1997) Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91: 649\u2013659","journal-title":"Cell"},{"key":"BF6601503_CR26","first-page":"509","volume":"10","author":"PA Kanetsky","year":"2001","unstructured":"Kanetsky PA, Holmes R, Walker A, Najarian D, Swoyer J, Guerry D, Halpern A, Rebbeck TR (2001) Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. Cancer Epidemiol Biomarkers Prev 10: 509\u2013513","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6601503_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1365-2133.1996.tb16218.x","volume":"134","author":"T Kato","year":"1996","unstructured":"Kato T, Suetake T, Sugiyama Y, Tabata N, Tagami H (1996) Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol 134: 383\u2013387","journal-title":"Br J Dermatol"},{"key":"BF6601503_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1470-2045(02)00894-X","volume":"3","author":"R Kefford","year":"2002","unstructured":"Kefford R, Bishop JN, Tucker M, Bressac-de Paillerets B, Bianchi-Scarra G, Bergman W, Goldstein A, Puig S, Mackie R, Elder D, Hansson J, Hayward N, Hogg D, Olsson H (2002) Genetic testing for melanoma. Lancet Oncol 3: 653\u2013654","journal-title":"Lancet Oncol"},{"key":"BF6601503_CR29","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1200\/JCO.1999.17.10.3245","volume":"17","author":"RF Kefford","year":"1999","unstructured":"Kefford RF, Newton Bishop JA, Bergman W, Tucker MA (1999) Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the melanoma genetics consortium. J Clin Oncol 17: 3245\u20133251","journal-title":"J Clin Oncol"},{"key":"BF6601503_CR30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1046\/j.0022-202x.2001.01421.x","volume":"117","author":"C Kennedy","year":"2001","unstructured":"Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bouwes Bavinck JN (2001) Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117: 294\u2013300","journal-title":"J Invest Dermatol"},{"key":"BF6601503_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1069>3.0.CO;2-A","volume":"95","author":"R Kumar","year":"2001","unstructured":"Kumar R, Smeds J, Berggren P, Straume O, Rozell BL, Akslen LA, Hemminki K (2001) A single nucleotide polymorphism in the 3\u2032untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Int J Cancer 95: 388\u2013393","journal-title":"Int J Cancer"},{"key":"BF6601503_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1098-2264(200004)27:4<358::AID-GCC4>3.0.CO;2-O","volume":"27","author":"G Lal","year":"2000","unstructured":"Lal G, Liu L, Hogg D, Lassam NJ, Redston MS, Gallinger S (2000) Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations. Genes Chromosomes Cancer 27: 358\u2013361","journal-title":"Genes Chromosomes Cancer"},{"key":"BF6601503_CR33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/5082","volume":"21","author":"L Liu","year":"1999","unstructured":"Liu L, Dilworth D, Gao L, Monzon J, Summers A, Lassam N, Hogg D (1999) Mutation of the CDKN2A 5\u2032 UTR creates an aberrant initiation codon and predisposes to melanoma. Nat Genet 21: 128\u2013132","journal-title":"Nat Genet"},{"key":"BF6601503_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1046\/j.1523-1747.1998.00267.x","volume":"111","author":"RM MacKie","year":"1998","unstructured":"MacKie RM, Andrew N, Lanyon WG, Connor JM (1998) CDKN2A germline mutations in UK patients with familial melanoma and multiple primary melanomas. J Invest Dermatol 111: 269\u2013272","journal-title":"J Invest Dermatol"},{"key":"BF6601503_CR35","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215","journal-title":"Nucleic Acids Res"},{"key":"BF6601503_CR36","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1056\/NEJM199803263381305","volume":"338","author":"J Monzon","year":"1998","unstructured":"Monzon J, Liu L, Brill H, Goldstein AM, Tucker MA, From L, McLaughlin J, Hogg D, Lassam NJ (1998) CDKN2A mutations in multiple primary melanomas. N Engl J Med 338: 879\u2013887","journal-title":"N Engl J Med"},{"key":"BF6601503_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1086\/302711","volume":"66","author":"JS Palmer","year":"2000","unstructured":"Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA (2000) Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 66: 176\u2013186","journal-title":"Am J Hum Genet"},{"key":"BF6601503_CR38","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1067\/mjd.2000.104687","volume":"42","author":"M Piepkorn","year":"2000","unstructured":"Piepkorn M (2000) Melanoma genetics: an update with focus on the CDKN2A(p16)\/ARF tumor suppressors. J Am Acad Dermatol 42: 705\u2013722 quiz 723-726","journal-title":"J Am Acad Dermatol"},{"key":"BF6601503_CR39","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0092-8674(00)81400-2","volume":"92","author":"J Pomerantz","year":"1998","unstructured":"Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA (1998) The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92: 713\u2013723","journal-title":"Cell"},{"key":"BF6601503_CR40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1182\/blood.V85.3.657.bloodjournal853657","volume":"85","author":"B Quesnel","year":"1995","unstructured":"Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Lai JL, Bauters F, Wattel E, Fenaux P (1995) p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 85: 657\u2013663","journal-title":"Blood"},{"key":"BF6601503_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/hmg\/10.1.55","volume":"10","author":"JA Randerson-Moor","year":"2001","unstructured":"Randerson-Moor JA, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Bishop JN, Bishop DT (2001) A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet 10: 55\u201362","journal-title":"Hum Mol Genet"},{"key":"BF6601503_CR42","doi-asserted-by":"publisher","first-page":"41424","DOI":"10.1074\/jbc.M105299200","volume":"276","author":"H Rizos","year":"2001","unstructured":"Rizos H, Darmanian AP, Holland EA, Mann GJ, Kefford RF (2001a) Mutations in the INK4a\/ARF melanoma susceptibility locus functionally impair p14ARF. J Biol Chem 276: 41424\u201341434","journal-title":"J Biol Chem"},{"key":"BF6601503_CR43","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1038\/sj.onc.1203629","volume":"19","author":"H Rizos","year":"2000","unstructured":"Rizos H, Darmanian AP, Mann GJ, Kefford RF (2000) Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization. Oncogene 19: 2978\u20132985","journal-title":"Oncogene"},{"key":"BF6601503_CR44","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.1038\/sj.onc.1204728","volume":"20","author":"H Rizos","year":"2001","unstructured":"Rizos H, Puig S, Badenas C, Malvehy J, Darmanian AP, Jimenez L, Mila M, Kefford RF (2001b) A melanoma-associated germline mutation in exon 1beta inactivates p14ARF. Oncogene 20: 5543\u20135547","journal-title":"Oncogene"},{"key":"BF6601503_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/26155","volume":"395","author":"AA Russo","year":"1998","unstructured":"Russo AA, Tong L, Lee JO, Jeffrey PD, Pavletich NP (1998) Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 395: 237\u2013243","journal-title":"Nature"},{"key":"BF6601503_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0923-1811(01)00085-8","volume":"26","author":"T Saida","year":"2001","unstructured":"Saida T (2001) Recent advances in melanoma research. J Dermatol Sci 26: 1\u201313","journal-title":"J Dermatol Sci"},{"key":"BF6601503_CR47","first-page":"3689","volume":"60","author":"CJ Sherr","year":"2000","unstructured":"Sherr CJ (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60: 3689\u20133695","journal-title":"Cancer Res"},{"key":"BF6601503_CR48","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s004010051107","volume":"98","author":"M Simon","year":"1999","unstructured":"Simon M, Koster G, Menon AG, Schramm J (1999) Functional evidence for a role of combined CDKN2A (p16-p14(ARF))\/CDKN2B (p15) gene inactivation in malignant gliomas. Acta Neuropathol (Berl) 98: 444\u2013452","journal-title":"Acta Neuropathol (Berl)"},{"key":"BF6601503_CR49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/hmg\/7.2.209","volume":"7","author":"N Soufir","year":"1998","unstructured":"Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, Benard J, Bressac-de Paillerets B (1998a) Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Hum Mol Genet 7: 209\u2013216","journal-title":"Hum Mol Genet"},{"key":"BF6601503_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/hmg\/7.2.209","volume":"7","author":"N Soufir","year":"1998","unstructured":"Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, Benard J, Bressac-de Paillerets B (1998b) Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]. Hum Mol Genet 7: 209\u2013216","journal-title":"Hum Mol Genet"},{"key":"BF6601503_CR51","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1093\/jnci\/92.22.1841","volume":"92","author":"N Soufir","year":"2000","unstructured":"Soufir N, Daya-Grosjean L, de La Salmoniere P, Moles JP, Dubertret L, Sarasin A, Basset-Seguin N (2000) Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients. J Natl Cancer Inst 92: 1841\u20131847","journal-title":"J Natl Cancer Inst"},{"key":"BF6601503_CR52","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00008571-199906000-00001","volume":"9","author":"RC Strange","year":"1999","unstructured":"Strange RC, Ellison T, Ichii-Jones F, Bath J, Hoban P, Lear JT, Smith AG, Hutchinson PE, Osborne J, Bowers B, Jones PW, Fryer AA (1999) Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma. Pharmacogenetics 9: 269\u2013276","journal-title":"Pharmacogenetics"},{"key":"BF6601503_CR53","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1001\/archderm.136.9.1118","volume":"136","author":"H Tsao","year":"2000","unstructured":"Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG (2000) Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Arch Dermatol 136: 1118\u20131122","journal-title":"Arch Dermatol"},{"key":"BF6601503_CR54","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1093\/hmg\/3.10.1841","volume":"3","author":"K Ueki","year":"1994","unstructured":"Ueki K, Rubio MP, Ramesh V, Correa KM, Rutter JL, von Deimling A, Buckler AJ, Gusella JF, Louis DN (1994) MTS1\/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Mol Genet 3: 1841\u20131845","journal-title":"Hum Mol Genet"},{"key":"BF6601503_CR55","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng1195-328","volume":"11","author":"P Valverde","year":"1995","unstructured":"Valverde P, Healy E, Jackson I, Rees JL, Thody AJ (1995) Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 11: 328\u2013330","journal-title":"Nat Genet"},{"key":"BF6601503_CR56","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/hmg\/4.10.1845","volume":"4","author":"GJ Walker","year":"1995","unstructured":"Walker GJ, Hussussian CJ, Flores JF, Glendening JM, Haluska FG, Dracopoli NC, Hayward NK, Fountain JW (1995) Mutations of the CDKN2\/p16INK4 gene in Australian melanoma kindreds. Hum Mol Genet 4: 1845\u20131852","journal-title":"Hum Mol Genet"},{"key":"BF6601503_CR57","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/jnci\/89.19.1460","volume":"89","author":"DC Whiteman","year":"1997","unstructured":"Whiteman DC, Milligan A, Welch J, Green AC, Hayward NK (1997) Germline CDKN2A mutations in childhood melanoma. J Natl Cancer Inst 89: 1460","journal-title":"J Natl Cancer Inst"},{"key":"BF6601503_CR58","first-page":"5612","volume":"60","author":"SL Winsey","year":"2000","unstructured":"Winsey SL, Haldar NA, Marsh HP, Bunce M, Marshall SE, Harris AL, Wojnarowska F, Welsh KI (2000) A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 60: 5612\u20135616","journal-title":"Cancer Res"},{"key":"BF6601503_CR59","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/jnci\/92.8.636","volume":"92","author":"CT Yang","year":"2000","unstructured":"Yang CT, You L, Yeh CC, Chang JW, Zhang F, McCormick F, Jablons DM (2000) Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells. J Natl Cancer Inst 92: 636\u2013641","journal-title":"J Natl Cancer Inst"},{"key":"BF6601503_CR60","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/jnci\/88.20.1489","volume":"88","author":"WG Yarbrough","year":"1996","unstructured":"Yarbrough WG, Aprelikova O, Pei H, Olshan AF, Liu ET (1996) Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele. J Natl Cancer Inst 88: 1489\u20131491","journal-title":"J Natl Cancer Inst"},{"key":"BF6601503_CR61","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.onc.1201600","volume":"16","author":"SM Zhuang","year":"1998","unstructured":"Zhuang SM, Schippert A, Haugen-Strano A, Wiseman RW, Soderkvist P (1998) Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2\u2032,3\u2032-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas. Oncogene 16: 803\u2013808","journal-title":"Oncogene"},{"key":"BF6601503_CR62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ng0196-97","volume":"12","author":"L Zuo","year":"1996","unstructured":"Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N, Dracopoli NC (1996) Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12: 97\u201399","journal-title":"Nat Genet"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601503.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601503","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/6601503.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T04:08:29Z","timestamp":1650341309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,20]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,1,26]]}},"alternative-id":["BF6601503"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601503","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,20]]},"assertion":[{"value":"15 May 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2003","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2003","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2004","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2011","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}